Nexavar

Rediff.com » News » Nexavar

News for Nexavar

Business

Bayer to appeal against patent order on Nexavar

Bayer AG has said it will approach the high court in Mumbai against a ruling by Intellectual Property Appellate Board that upheld the compulsory licence issued to India's Natco Pharma to make and......

India refutes US criticism of its FDI, IPR laws

The US has criticised India, saying it doesn’t have adequate protection for intellectual property rights (IPR), hinting at the recent Supreme Court decision denying a patent to a Swiss......

Should pharma MNCs be peeved?

To conclude from the judgment that the country has scant respect for patents appears far-fetched, notes Bhupesh Bhandari.Multinational pharmaceutical companies complain that India has become a......

Column: What was the Novartis case really about?

Arvind Subramanian answers five questions on the disputed Novartis ruling.On April 1, the Indian Supreme Court rejected the attempt by Novartis, the Swiss pharmaceutical company, to patent a new......

BDR wrestles Big Pharma in patents match

A month ago, Dharmesh Shah had enough time to spare for day-to-day activities of a lesser-known company -- BDR Pharma -- where he serves as chairman & managing director.However, in the last one......

Web results for Nexavar

Bayer to Present New Data Across Oncology Portfolio at ASCO 2013

/PRNewswire/ -- Intended for U.S. Media Only--Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar®... ...

http://www.asianhhm.com/news/news_archives.asp?NewsID=45388

Bayer Initiates Phase III Trial of Stivarga® (regorafenib) Tablets in Patients with Advanced Liver Cancer

/PRNewswire/ -- Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with... ...

http://www.asianhhm.com/news/news_archives.asp?NewsID=45206

US urged to take tougher line on trade practices

By Doug Palmer WASHINGTON (Reuters) - A U.S. think tank on Tuesday recommended Congress suspend trade benefits for India, in the latest sign of... ...

http://in.reuters.com/article/2013/05/15/usa-india-trade-idINDEE94D0H320130515

Incentivising Innovation without compromising affordable healthcare

The recent judgement of the Supreme Court of India in the case of Novartis AG v Union of India[1] has highlighted the protective provisions of... ...

http://www.barandbench.com/content/indian-patents-act-incentivising-innovation-without-compromising-affordable-healthcare

Narrower Loss from Onyx, Guidance Maintained - Analyst Blog

Narrower Loss from Onyx, Guidance Maintained Onyx Pharmaceuticals Inc. (ONXX) reported a loss of 32 cents per share in the first quarter of 2013,... ...

http://in.quote.com/news/zacksCache.aspx?id=700919

See All

Rediff News

Nexavar

News for Nexavar

Bayer to appeal against patent order on Nexavar

India refutes US criticism of its FDI, IPR laws

Should pharma MNCs be peeved?

Column: What was the Novartis case really about?

BDR wrestles Big Pharma in patents match

Related Tags

Top Coverage News

Indian Premier League - IPL 2013

Coverage: The Match-Fixing Episode II - spot-fixing trial

Sachin Tendulkar : Cup of praise overfloweth - Reactions

Complete coverage of Mumbai blasts

Decoding India’s Corruption Wars - Ajit Balakrishnan's Blog